These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8257076

  • 1. Galloway Memorial Lecture. Protein engineering of tumor necrosis factor-beta and its applications in cancer, septicaemia and cachexia.
    Goh CR.
    Ann Acad Med Singap; 1993 Jul; 22(4):651-6. PubMed ID: 8257076
    [Abstract] [Full Text] [Related]

  • 2. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).
    Goh CR, Loh CS, Porter AG.
    Protein Eng; 1991 Oct; 4(7):785-91. PubMed ID: 1665907
    [Abstract] [Full Text] [Related]

  • 3. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M, Simoni P, Antonetti F.
    J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
    [Abstract] [Full Text] [Related]

  • 4. Membrane lymphotoxin is required for resistance to Theiler's virus infection.
    Lin X, Ma X, Rodriguez M, Feng X, Zoecklein L, Fu YX, Roos RP.
    Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel muteins of human tumor necrosis factor alpha.
    Ito R, Matsumoto H, Uchida K, Kubo T, Tsukii Y, Endo T, Kaji A.
    Biochim Biophys Acta; 1991 Apr 15; 1096(3):245-52. PubMed ID: 2018798
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K, Bienvenu J, Coiffier B, Salles G.
    Eur Cytokine Netw; 1995 Apr 15; 6(2):83-96. PubMed ID: 7578992
    [Abstract] [Full Text] [Related]

  • 8. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.
    Lu G, Janjic BM, Janjic J, Whiteside TL, Storkus WJ, Vujanovic NL.
    J Immunol; 2002 Feb 15; 168(4):1831-9. PubMed ID: 11823516
    [Abstract] [Full Text] [Related]

  • 9. [Tumor necrosis factor alpha and beta (TNF-alpha and -beta) in pathogenesis of rheumatoid arthritis].
    Yamamura M.
    Nihon Rinsho; 2005 Jan 15; 63 Suppl 1():145-52. PubMed ID: 15799335
    [No Abstract] [Full Text] [Related]

  • 10. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
    Reddy J, Chastagner P, Fiette L, Liu X, Thèze J.
    Int Immunol; 2001 Feb 15; 13(2):135-47. PubMed ID: 11157847
    [Abstract] [Full Text] [Related]

  • 11. Tumour necrosis factors in clinical practice.
    Goh CR.
    Ann Acad Med Singap; 1990 Mar 15; 19(2):235-9. PubMed ID: 2189343
    [Abstract] [Full Text] [Related]

  • 12. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE, Barrett K, Turner M, Brown A, Kissonerghis AM, Gadnell M, Gray PW, Chernajovsky Y, Feldmann M.
    Eur J Biochem; 1994 Aug 01; 223(3):831-40. PubMed ID: 8055960
    [Abstract] [Full Text] [Related]

  • 13. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M.
    Eur Cytokine Netw; 1998 Sep 01; 9(3):255-62. PubMed ID: 9831174
    [Abstract] [Full Text] [Related]

  • 14. [Bone resorption and cytokines: the role of IL-1 beta, TNF and lymphotoxin].
    Piattelli A, Trisi P, D'Addona A.
    Minerva Stomatol; 1990 Jun 01; 39(6):447-51. PubMed ID: 2204796
    [Abstract] [Full Text] [Related]

  • 15. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
    Li DH, Havell EA, Brown CL, Cullen JM.
    Gene; 2000 Jan 25; 242(1-2):295-305. PubMed ID: 10721723
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS, Berger AE, Ware CF.
    J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F, Bourdon PR, Griffiths DA, Lawton P, Zafari M, Sizing ID, Miatkowski K, Ngam-ek A, Benjamin CD, Hession C, Ambrose CM, Meier W, Browning JL.
    J Immunol; 1997 Oct 01; 159(7):3299-310. PubMed ID: 9317128
    [Abstract] [Full Text] [Related]

  • 18. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R, Cuff CA, Lesslauer W, Ruddle NH.
    J Immunol; 1998 Jan 01; 160(1):485-91. PubMed ID: 9552007
    [Abstract] [Full Text] [Related]

  • 19. Human tumour necrosis factors-alpha and -beta: differences in their structure, expression and biological properties.
    Porter AG.
    FEMS Microbiol Immunol; 1990 Nov 01; 2(4):193-9. PubMed ID: 2285517
    [Abstract] [Full Text] [Related]

  • 20. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors.
    Schoenfeld HJ, Poeschl B, Frey JR, Loetscher H, Hunziker W, Lustig A, Zulauf M.
    J Biol Chem; 1991 Feb 25; 266(6):3863-9. PubMed ID: 1847389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.